NIDEC PHARMA
InactiveInactive; last annual accounts for fiscal year 2023.
Signals
Two signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Two or more financial years not filed
Since the financial year that closed on 31-12-2024, 2 financial years are missing at the National Bank. A company this far behind goes bankrupt within the year nineteen times as often as a punctual filer.
NBB · 10 filingsPosition against the passed deadline
31-12-2024 close31-07-2025 deadline30-09-2026 today
neutral · Filed after the deadline
The financial year that closed on 31-12-2023 was due by 31-07-2024 and was filed on 22-08-2024, 22 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
not filed
2023
22 d late
2022
29 d late
2021
18 d early
2020
37 d early
2019
35 d early
← before the deadline
after the deadline →
tick = median of all Belgian filings
This company filed its last 5 accounts on average 8 days before the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.
Checked, nothing found (1)
Financials · fiscal year 2023, micro schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€62,618▲ 11.0%
2022 · €56,437
Working capital
-€472,240▲ 11.7%
2022 · -€534,673
Trend over the years
Click a name to add, emphasise or remove a line.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20192020202120222023
Operating result€82,347▼ 3.6%€89,103▲ 8.2%€90,427▲ 1.5%€78,968▼ 12.7%€85,307▲ 8.0%
Net result€69,068▼ 5.6%€64,962▼ 5.9%€63,511▼ 2.2%€56,437▼ 11.1%€62,618▲ 11.0%
Equity-€799,686▲ 8.0%-€754,723▲ 5.6%-€691,212▲ 8.4%-€634,775▲ 8.2%-€572,157▲ 9.9%
Total assets€95,527▲ 23.8%€114,934▲ 20.3%€130,829▲ 13.8%€142,961▲ 9.3%€141,966▼ 0.7%
Debt€895,212▼ 5.4%€869,658▼ 2.9%€822,041▼ 5.5%€777,736▼ 5.4%€714,124▼ 8.2%
Working capital-€541,263▲ 4.2%-€548,500▼ 1.3%-€543,828▲ 0.9%-€534,673▲ 1.7%-€472,240▲ 11.7%
Result per fiscal year
Operating resultNet result
The operating result recovers in 2023; 2023 is 8% above 2022.
Balance-sheet composition
2023 in colour, 2022 as the grey bar beneath
Assets €141,966
Fixed assets
€83 =
Current assets
€141,884 ▼ 0.7%
Key figures and ratios
Solvency
-403.0%▲
2022 · -444.0%
Current ratio
0.23▲
2022 · 0.21
Debt to equity
-1.25▼
2022 · -1.23
ROA
44.1%▲
2022 · 39.5%
Debt ≤ 1 year
€614,124▼
2022 · €677,551
Debt > 1 year
€100,000=
2022 · €100,000
Income taxes
€21,213▲
2022 · €18,879
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2019 | 2020 | 2021 | 2022 | 2023 | Change |
|---|---|---|---|---|---|---|
| Gross operating margin9900 | €82,347 | €89,103 | €90,427 | €78,968 | €85,307 | ▲ 8.0% |
| Operating profit (loss)9901 | €82,347 | €89,103 | €90,427 | €78,968 | €85,307 | ▲ 8.0% |
| Recurring financial income75 | €0 | - | - | - | - | - |
| Financial charges65/66B | - | - | €5,722 | €3,652 | €1,475 | ▼ 59.6% |
| Recurring financial charges65 | €9,772 | €7,707 | €5,722 | €3,652 | €1,475 | ▼ 59.6% |
| Profit (loss) for the period before taxes9903 | €72,575 | €81,396 | €84,704 | €75,316 | €83,831 | ▲ 11.3% |
| Income taxes67/77 | €3,507 | €16,434 | €21,193 | €18,879 | €21,213 | ▲ 12.4% |
| Profit (loss) for the period9904 | €69,068 | €64,962 | €63,511 | €56,437 | €62,618 | ▲ 11.0% |
| Profit (loss) for the period to be appropriated9905 | €69,068 | €64,962 | €63,511 | €56,437 | €62,618 | ▲ 11.0% |
| Line | 2019 | 2020 | 2021 | 2022 | 2023 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €95,527 | €114,934 | €130,829 | €142,961 | €141,966 | ▼ 0.7% |
| Fixed assets21/28 | €83 | €83 | €83 | €83 | €83 | = |
| Financial fixed assets28 | €83 | €83 | €83 | €83 | €83 | = |
| Current assets29/58 | €95,444 | €114,852 | €130,747 | €142,878 | €141,884 | ▼ 0.7% |
| Amounts receivable within one year40/41 | €89,544 | €109,066 | €123,325 | €135,545 | €139,326 | ▲ 2.8% |
| Trade receivables40 | - | - | - | €115,120 | - | - |
| Other amounts receivable41 | - | - | €123,325 | €20,426 | €139,326 | ▲ 582% |
| Cash at bank and in hand54/58 | €5,900 | €5,786 | €7,422 | €7,333 | €2,557 | ▼ 65.1% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €95,527 | €114,934 | €130,829 | €142,961 | €141,966 | ▼ 0.7% |
| Equity10/15 | -€799,686 | -€754,723 | -€691,212 | -€634,775 | -€572,157 | ▲ 9.9% |
| Contributions10/11 | €61,973 | €61,973 | €61,973 | €61,973 | €61,973 | = |
| Capital10 | - | - | €61,973 | €61,973 | €61,973 | = |
| Issued capital100 | - | - | €61,973 | €61,973 | €61,973 | = |
| Reserves13 | €6,197 | €6,197 | €6,197 | €6,197 | €6,197 | = |
| Non-distributable reserves130/1 | - | - | €6,197 | €6,197 | €6,197 | = |
| Legal reserve130 | - | - | €6,197 | €6,197 | €6,197 | = |
| Profit (loss) carried forward14 | -€867,856 | -€822,894 | -€759,383 | -€702,946 | -€640,328 | ▲ 8.9% |
| Amounts payable17/49 | €895,212 | €869,658 | €822,041 | €777,736 | €714,124 | ▼ 8.2% |
| Amounts payable after more than one year17 | €253,683 | €201,489 | €147,088 | €100,000 | €100,000 | = |
| Financial debts170/4 | - | - | €47,088 | - | - | - |
| Other amounts payable178/9 | - | - | €100,000 | €100,000 | €100,000 | = |
| Amounts payable within one year42/48 | €636,707 | €663,352 | €674,575 | €677,551 | €614,124 | ▼ 9.4% |
| Current portion of amounts payable after more than one year42 | - | - | €58,834 | €51,708 | - | - |
| Financial debts43 | - | - | €11,710 | €11,730 | €9,438 | ▼ 19.5% |
| Credit institutions430/8 | - | - | €11,710 | €11,730 | €9,438 | ▼ 19.5% |
| Trade debts44 | - | - | €80 | €35,000 | - | - |
| Suppliers440/4 | - | - | €80 | €35,000 | - | - |
| Taxes, remuneration and social security45 | - | - | €17,627 | €1,193 | €5,213 | ▲ 337% |
| Taxes450/3 | - | - | €17,627 | €1,193 | €5,213 | ▲ 337% |
| Other amounts payable47/48 | - | - | €586,324 | €577,921 | €599,472 | ▲ 3.7% |
| Accrued charges and deferred income492/3 | - | - | €379 | €185 | - | - |
| Line | 2019 | 2020 | 2021 | 2022 | 2023 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €69,068 | €64,962 | €63,511 | €56,437 | €62,618 | ▲ 11.0% |
| Operating cash flow (approximation) | €69,068 | €64,962 | €63,511 | €56,437 | €62,618 | ▲ 11.0% |
| Investment in fixed assets (approximation) | - | €0 | €0 | €0 | €0 | - |
| Change in cash | - | -€114 | €1,636 | -€89 | -€4,775 | ▼ 5,255% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
2024
22-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 22 days late
2023
29-08
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 29 days late
2022
31-12
Financial
Weakest financial yearnet €56,437 ▼11.1%
Net result drops to €56,437, the lowest in the series.
13-07
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
2021
24-06
NBB filing
Annual accounts filed
fiscal year 2020 · full schema
2020
26-06
NBB filing
Annual accounts filed
fiscal year 2019 · full schema
2019
19-07
NBB filing
Annual accounts filed
fiscal year 2018 · full schema
2018
29-06
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
29-06
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema
2016
12-08
NBB filing
Annual accounts filed
fiscal year 2015 · full schema · 12 days late
2015
17-06
NBB filing
Annual accounts filed
fiscal year 2014 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 7 acts read
About the unread acts
We know of 7 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Structure & network
Owners and holdings
1 ownerChain of control
- SOPHADE
- NIDEC PHARMA
Highest known parent: SOPHADE. The sources do not say who stands above it.
Owners 1
- SOPHADEparentSourceaccounts SOPHADE 2023100%
Holdings 0
No holding stated in the accounts, acts or LEI register we read.
According to the annual accounts of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No current directors or connected companies found in the register.